{"AllianceGenome": "3168", "HGNC": "3168", "MIM": "605110", "_id": "9170", "_version": 1, "accession": {"genomic": ["AC002306.1", "AC011458.7", "CH471106.1", "CP068259.2", "HF583779.1", "JB028785.1", "NC_000019.10", "NC_060943.1"], "protein": ["AAB61528.1", "AAC27728.1", "AAF43409.1", "AAG28521.1", "AAH25695.1", "AAP84361.1", "BAG38162.1", "BAG53861.1", "CCQ43276.1", "CCV20022.1", "EAW84836.1", "EAW84837.1", "NP_001382589.1", "Q9HBW0.3"], "rna": ["AF011466.1", "AF197929.1", "AF233092.1", "AK123043.1", "AK316573.1", "AU133824.1", "AY322548.1", "BC025695.1", "BM840024.1", "NM_001395660.1", "NM_004720.7"], "translation": [{"protein": "AAC27728.1", "rna": "AF011466.1"}, {"protein": "AAG28521.1", "rna": "AF197929.1"}, {"protein": "BAG38162.1", "rna": "AK316573.1"}, {"protein": "AAP84361.1", "rna": "AY322548.1"}, {"protein": "AAH25695.1", "rna": "BC025695.1"}, {"protein": "BAG53861.1", "rna": "AK123043.1"}, {"protein": "AAF43409.1", "rna": "AF233092.1"}, {"protein": "NP_001382589.1", "rna": "NM_001395660.1"}]}, "alias": ["EDG-4", "EDG4", "LPA-2", "LPA2"], "ensembl": {"gene": "ENSG00000064547", "protein": ["ENSP00000384665", "ENSP00000443256", "ENSP00000465206", "ENSP00000465280", "ENSP00000466112", "ENSP00000466940", "ENSP00000468132"], "transcript": ["ENST00000407877", "ENST00000542587", "ENST00000586703", "ENST00000588233", "ENST00000588461", "ENST00000589311", "ENST00000590629", "ENST00000591042", "ENST00000592061"], "translation": [{"protein": "ENSP00000384665", "rna": "ENST00000407877"}, {"protein": "ENSP00000465280", "rna": "ENST00000586703"}, {"protein": "ENSP00000443256", "rna": "ENST00000542587"}, {"protein": "ENSP00000468132", "rna": "ENST00000591042"}, {"protein": "ENSP00000466112", "rna": "ENST00000588233"}, {"protein": "ENSP00000465206", "rna": "ENST00000592061"}, {"protein": "ENSP00000466940", "rna": "ENST00000588461"}], "type_of_gene": "protein_coding"}, "entrezgene": "9170", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 8.34412255365, "exp_mis": 166.428337485, "exp_syn": 68.3638613973, "lof_z": 2.17555929416764, "mis_z": 1.76029605095238, "mu_lof": 7.12196406524e-07, "mu_mis": 1.56593144942e-05, "mu_syn": 6.37979048427e-06, "n_lof": 2.0, "n_mis": 120.0, "n_syn": 60.0, "p_li": 0.337269896843433, "p_null": 0.0145434554591211, "p_rec": 0.648186647697445, "syn_z": 0.627108784774892}, "bp": 1056, "cds_end": 19738093, "cds_start": 19735064, "n_exons": 2, "nonpsych": {"exp_lof": 7.51285267888, "exp_mis": 150.594326317, "exp_syn": 61.836513465, "lof_z": 1.97526761383881, "mis_z": 1.6273844700513, "mu_lof": 7.12196406524e-07, "mu_mis": 1.56593144942e-05, "mu_syn": 6.37979048427e-06, "n_lof": 2.0, "n_mis": 111.0, "n_syn": 53.0, "p_li": 0.296695619570702, "p_null": 0.0239066777994032, "p_rec": 0.679397702629895, "syn_z": 0.707492502143649}, "nontcga": {"exp_lof": 7.67275433697, "exp_mis": 153.110243041, "exp_syn": 62.8909220682, "lof_z": 2.02022436431969, "mis_z": 1.81628053623046, "mu_lof": 7.12196406524e-07, "mu_mis": 1.56593144942e-05, "mu_syn": 6.37979048427e-06, "n_lof": 2.0, "n_mis": 108.0, "n_syn": 52.0, "p_li": 0.290394798478069, "p_null": 0.0208599520933954, "p_rec": 0.688745249428535, "syn_z": 0.869546702384593}, "transcript": "ENST00000542587.1"}, "exons": [{"cdsend": 19627284, "cdsstart": 19624255, "chr": "19", "position": [[19623655, 19624569], [19626542, 19627284], [19628091, 19628220]], "strand": -1, "transcript": "NM_004720", "txend": 19628220, "txstart": 19623655}], "exons_hg19": [{"cdsend": 19738093, "cdsstart": 19735064, "chr": "19", "position": [[19734465, 19735378], [19737351, 19738093], [19738900, 19739029]], "strand": -1, "transcript": "NM_004720", "txend": 19739029, "txstart": 19734465}], "generif": [{"pubmed": 12123830, "text": "demonstrate that two biological fluids, blood plasma and seminal plasma, differentially activate LPA receptors"}, {"pubmed": 12668280, "text": "results suggested that LPA(2) and LPA(3) may be involved in VEGF expression mediated by LPA signals in human ovarian oncogenesis"}, {"pubmed": 12759391, "text": "LPA may directly increase the level of cyclin D1 in ovarian cancer cells, increasing their proliferation."}, {"pubmed": 15535846, "text": "Upregulation of LPA2 may play a role in carcinogenesis, particularly in postmenopausal breast cancer."}, {"pubmed": 15728708, "text": "LPA2 is the major LPA receptor in colon cancer cells and cellular signals by LPA2 are largely mediated through its ability to interact with NHERF2."}, {"pubmed": 15755723, "text": "formation of the LPA receptor/PDZ domain-containing RhoGEF complex plays a pivotal role in LPA-induced RhoA activation"}, {"pubmed": 16904289, "text": "These results demonstrate that MAGI-3 interacts directly with LPA(2) and regulates the ability of LPA(2) to activate Erk and RhoA."}, {"pubmed": 17496233, "text": "EDG4 and EDG2 cooperate to promote LPA-stimulated chemotaxis in breast tumor cell lines."}, {"pubmed": 17765657, "text": "data suggest that LPA receptor-dependent expression of CTGF and CYR61 represents a common host response after interaction with bacteria."}, {"pubmed": 17965021, "text": "lysophosphatidic acid 2 receptor mediates down-regulation of Siva-1 to promote cell survival"}, {"pubmed": 18703779, "text": "A role for the transgenic lysophosphatidic acid (LPA)2 receptor is identified in regulating smooth muscle cell migratory responses in the context of vascular injury."}, {"pubmed": 18754873, "text": "LPA and LPA receptors, LPA(2) as well as LPA(1), represent potential therapeutic targets for patients with MPM"}, {"pubmed": 19001604, "text": "Expression of LPA2 during ovarian carcinogenesis contributes to ovarian cancer aggressiveness, suggesting that the targeting of LPA production and action may have potential for the treatment of ovarian cancer."}, {"pubmed": 19025891, "text": "Switching of LPA receptor expression from LPA3 to LPA1, may be involved in prostate cancer progression and/or androgen independence"}, {"pubmed": 19081821, "text": "LPA(1) receptor, LPA(2) and LPA(3) receptors-induced VASP phosphorylation is a critical mediator of tumor cell migration initiation"}, {"pubmed": 19116446, "text": "LPA2 and Gi/Src pathways are significant for LPA-induced COX-2 expression and cell migration that could be a promising drug target for ovarian cancer cell metastasis."}, {"pubmed": 19860625, "text": "Data show that CLL cells express LPA receptors LPA(1-5) and VEGF receptors, and the plasma levels of VEGF are elevated in CLL patients."}, {"pubmed": 19899077, "text": "show that human microglia express LPA receptor subtypes LPA(1), LPA(2), and LPA(3) on mRNA and protein level. LPA activation of C13NJ cells induced Rho and extracellular signal-regulated kinase activation and enhanced cellular ATP production."}, {"pubmed": 20890765, "text": "LPA2 gene mutation may play some role in the pathogenesis of colon cancer."}, {"pubmed": 21134377, "text": "MAGI-3 competes with NHERF-2 to negatively regulate LPA2 receptor signaling in colon cancer cells."}, {"pubmed": 21234797, "text": "This work shows for the first time that key components of the LPA pathway are modulated following traumatic brain injuries in humans."}, {"pubmed": 21964883, "text": "found that LPA receptor 2/3-mediated IL-8 expression occurs through Gi/PI3K/AKT, Gi/PKC and IkappaB/NF-kappaB signaling"}, {"pubmed": 23084965, "text": "LPA2 and LPA6 receptor subtypes are predominant in both HPAECs and HMVECs"}, {"pubmed": 23569130, "text": "Lysophosphatidic acid (LPA) increased hepatocellular carcinoma cells cell invasion, which was LPA-receptor dependent."}, {"pubmed": 24061591, "text": "LPA1 and LPA2 are major LPA receptor subtypes compared with low-expressed LPA3 in PANC-1 tumor cells."}, {"pubmed": 24613836, "text": "Crystal structure of NHERF2 PDZ1 domain complex with C-terminal LPA2 sequence. The PDZ1-LPA2 binding specificity is achieved by hydrogen bonds and hydrophobic contacts with the last four LPA2 residues contributing to specific interactions."}, {"pubmed": 24950964, "text": "the RhoA-regulated formin Dia1 is involved in entosis downstream of LPAR2"}, {"pubmed": 25463482, "text": "Suggest that LPA2 and LPA3 may function as a molecular switch and play opposing roles during megakaryopoiesis of K562 cells."}, {"pubmed": 26327335, "text": "Data show high expression levels of LPAR2 and LPAR1 in endometrial cancer tissue with positive correlations with FIGO stage suggesting them as potential biomarkers for endometrial cancer progression."}, {"pubmed": 26937138, "text": "LPAR2 mRNA is up-regulation in colorectal cancer."}, {"pubmed": 27124742, "text": "epithelial dysplasia was observed in founder mouse intestine, correlating LPA2 overexpression with epithelial dysplasia. The current study demonstrates that overexpression of LPA2 alone can lead to intestinal dysplasia."}, {"pubmed": 27244685, "text": "The results indicate that LPA2 and LPA3 receptors play opposing roles during red blood cells differentiation."}, {"pubmed": 27583415, "text": "LPA2 mRNA levels were associated with poorer differentiation, and higher LPA6 levels were associated with microvascular invasion in HCC; both became a risk factor for recurrence after surgical treatment when combined with increased serum ATX levels"}, {"pubmed": 27805252, "text": "LPA2 expression was associated with HIF-1alpha expression and that a high level of LPA2 was associated with shorter overall survival and was an independent prognostic predictor for breast cancer in Chinese women."}, {"pubmed": 28205098, "text": "These results suggest that LPA signaling via LPA2 may play an important role in the regulation of cellular functions in HT1080 cells treated with cisplatin."}, {"pubmed": 29621954, "text": "Study shows that due to the high LPAR2 and LPAR4 transcript and protein expression in endometriotic ovarian cysts and positive correlations of both these receptors with the PR-B and ERbeta, respectively, those receptors seem to be the most promising predictors of the endometriotic cysts."}, {"pubmed": 29859140, "text": "Investigated the roles of LPA receptors in the regulation of cellular functions during tumor progression in osteosarcoma cell lines. MG63-R7-C cell activities were inhibited by LPA2 knockdown, suggesting that LPA signaling via LPA2 plays an important role in the acquisition of malignant properties during tumor progression in MG-63 cells."}, {"pubmed": 30093116, "text": "LPAR2 and LPAR5 regulate cellular functions during tumor progression in fibrosarcoma HT1080 cells."}, {"pubmed": 31115486, "text": "It was revealed that LPA may stimulate the expression of Notch1 and Hes family bHLH transcription factor 1, and the phosphorylation of protein kinase B which belongs to the Notch pathway."}, {"pubmed": 31235682, "text": "The positive expression rate of LPA2 and KLF5 were statistical different in gastric adenocarcinoma, GIN, and normal gastric tissue (P<0.05). LPA2 positive expression was associated with tumor invasion depth, Lauren type, vascular invasion, local lymph node metastasis, and clinical stage (P<0.05)."}, {"pubmed": 32006610, "text": "Effects of lysophosphatidic acid (LPA) receptor-2 (LPA2) and LPA3 on the regulation of chemoresistance to anticancer drug in lung cancer cells."}, {"pubmed": 33347862, "text": "Roles of endothelial cells in the regulation of cell motility via lysophosphatidic acid receptor-2 (LPA2) and LPA3 in osteosarcoma cells."}, {"pubmed": 33406026, "text": "Transcriptional regulation of lysophosphatidic acid receptors 2 and 3 regulates myeloid commitment of hematopoietic stem cells."}, {"pubmed": 33959968, "text": "BRET analysis reveals interaction between the lysophosphatidic acid receptor LPA2 and the lysophosphatidylinositol receptor GPR55 in live cells."}, {"pubmed": 35241179, "text": "LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma."}, {"pubmed": 35799024, "text": "Estrogen-increased SGK1 Promotes Endometrial Stromal Cell Invasion in Adenomyosis by Regulating with LPAR2."}, {"pubmed": 35857125, "text": "LPAR2-mediated action promotes human renal cell carcinoma via MAPK/NF-kappaB signaling to regulate cytokine network."}], "genomic_pos": {"chr": "19", "end": 19628930, "ensemblgene": "ENSG00000064547", "start": 19623655, "strand": -1}, "genomic_pos_hg19": {"chr": "19", "end": 19739739, "start": 19734477, "strand": -1}, "go": {"BP": [{"evidence": "TAS", "gocategory": "BP", "id": "GO:0007186", "pubmed": 9525886, "qualifier": "involved_in", "term": "G protein-coupled receptor signaling pathway"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0007189", "qualifier": "involved_in", "term": "adenylate cyclase-activating G protein-coupled receptor signaling pathway"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0007204", "pubmed": 9804623, "qualifier": "involved_in", "term": "positive regulation of cytosolic calcium ion concentration"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0019222", "qualifier": "involved_in", "term": "regulation of metabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0035025", "qualifier": "involved_in", "term": "positive regulation of Rho protein signal transduction"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0043410", "qualifier": "involved_in", "term": "positive regulation of MAPK cascade"}], "CC": [{"evidence": "IBA", "gocategory": "CC", "id": "GO:0005737", "qualifier": "is_active_in", "term": "cytoplasm"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005886", "qualifier": "is_active_in", "term": "plasma membrane"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0009986", "pubmed": 19306925, "qualifier": "located_in", "term": "cell surface"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0030139", "pubmed": 19306925, "qualifier": "colocalizes_with", "term": "endocytic vesicle"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0048787", "qualifier": "located_in", "term": "presynaptic active zone membrane"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0098978", "qualifier": "located_in", "term": "glutamatergic synapse"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0004930", "qualifier": "enables", "term": "G protein-coupled receptor activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [14688263, 16203867, 19306925], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "TAS", "id": "GO:0008289", "pubmed": 9525886, "qualifier": "enables", "term": "lipid binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0030165", "qualifier": "enables", "term": "PDZ domain binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0070915", "qualifier": "enables", "term": "lysophosphatidic acid receptor activity"}]}, "homologene": {"genes": [[7955, 567956], [8364, 493190], [9031, 426086], [9544, 719844], [9598, 455878], [9606, 9170], [9615, 484802], [9913, 509748], [10090, 53978], [10116, 498609]], "id": 3465}, "interpro": [{"desc": "G protein-coupled receptor, rhodopsin-like", "id": "IPR000276", "short_desc": "GPCR_Rhodpsn"}, {"desc": "Lysophosphatidic acid receptor", "id": "IPR004065", "short_desc": "LPA_rcpt"}, {"desc": "Lysophosphatidic acid receptor EDG-4", "id": "IPR004066", "short_desc": "LPA_rcpt_EDG4"}, {"desc": "GPCR, rhodopsin-like, 7TM", "id": "IPR017452", "short_desc": "GPCR_Rhodpsn_7TM"}], "ipi": "IPI00172675", "map_location": "19p13.11", "name": "lysophosphatidic acid receptor 2", "other_names": ["G protein-coupled receptor", "LPA receptor 2", "LPA receptor EDG4", "endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 4", "lysophosphatidic acid receptor 2", "lysophosphatidic acid receptor EDG4", "lysophosphatidic acid receptor Edg-4"], "pantherdb": {"HGNC": "3168", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1858422", "ortholog_type": "LDO", "panther_family": "PTHR22750", "taxid": 10090, "uniprot_kb": "Q9JL06"}, {"RGD": "1561336", "ortholog_type": "LDO", "panther_family": "PTHR22750", "taxid": 10116, "uniprot_kb": "A0A0G2K505"}, {"Ensembl": "ENSGALG00000042767", "ortholog_type": "LDO", "panther_family": "PTHR22750", "taxid": 9031, "uniprot_kb": "A0A1D5PTQ5"}, {"ZFIN": "ZDB-GENE-051120-99", "ortholog_type": "O", "panther_family": "PTHR22750", "taxid": 7955, "uniprot_kb": "F1Q734"}, {"ZFIN": "ZDB-GENE-040801-97", "ortholog_type": "LDO", "panther_family": "PTHR22750", "taxid": 7955, "uniprot_kb": "F1QFF1"}], "uniprot_kb": "Q9HBW0"}, "pathway": {"biocarta": {"id": "akap13pathway", "name": "rho-selective guanine exchange factor akap13 mediates stress fiber formation"}, "kegg": [{"id": "hsa04015", "name": "Rap1 signaling pathway - Homo sapiens (human)"}, {"id": "hsa04072", "name": "Phospholipase D signaling pathway - Homo sapiens (human)"}, {"id": "hsa04080", "name": "Neuroactive ligand-receptor interaction - Homo sapiens (human)"}, {"id": "hsa04151", "name": "PI3K-Akt signaling pathway - Homo sapiens (human)"}, {"id": "hsa04810", "name": "Regulation of actin cytoskeleton - Homo sapiens (human)"}, {"id": "hsa05130", "name": "Pathogenic Escherichia coli infection - Homo sapiens (human)"}, {"id": "hsa05200", "name": "Pathways in cancer - Homo sapiens (human)"}], "pid": {"id": "lysophospholipid_pathway", "name": "LPA receptor mediated events"}, "wikipathways": [{"id": "WP3932", "name": "Focal Adhesion-PI3K-Akt-mTOR-signaling pathway"}, {"id": "WP4172", "name": "PI3K-Akt signaling pathway"}]}, "pfam": "PF00001", "pharmgkb": "PA162394202", "pharos": {"target_id": 3376, "tdl": "Tchem"}, "prosite": "PS50262", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF259731", "relationship": "is"}, {"id": "GNF259732", "relationship": "is"}, {"id": "GNF259733", "relationship": "is"}, {"id": "GNF259734", "relationship": "is"}], "GNF_hs-GPCR_IDT-siRNA": [{"id": "GNF280476", "relationship": "is"}, {"id": "GNF280477", "relationship": "is"}, {"id": "GNF280478", "relationship": "is"}, {"id": "GNF280479", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF161987", "relationship": "is"}, "GNF_hs-Origene": {"id": "GNF036449", "relationship": "is"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF082091", "relationship": "is"}, {"id": "GNF082092", "relationship": "is"}, {"id": "GNF086270", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF052758", "relationship": "is"}, {"id": "GNF057527", "relationship": "is"}, {"id": "GNF060696", "relationship": "is"}, {"id": "GNF072619", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF069031", "relationship": "is"}, {"id": "GNF069032", "relationship": "is"}], "GNF_hs_LentiORF-HA-MYC": {"id": "GNF282904", "relationship": "is"}, "GNF_hs_LentiORF-Jred": {"id": "GNF283831", "relationship": "is"}, "GNF_mm+hs-MGC": {"id": "GNF003972", "relationship": "is"}, "GNF_mm+hs_RetroCDNA": {"id": "GNF242960", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF093716", "relationship": "is"}, {"id": "GNF133374", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000019.10", "NC_060943.1"], "protein": "NP_001382589.1", "rna": ["NM_001395660.1", "NM_004720.7"], "translation": {"protein": "NP_001382589.1", "rna": "NM_001395660.1"}}, "reporter": {"HG-U133_Plus_2": ["206722_s_at", "206723_s_at"], "HG-U95Av2": "37769_at", "HTA-2_0": "TC19001305.hg.1", "HuEx-1_0": "3855856", "HuGene-1_1": "8035703", "HuGene-2_1": "16870658"}, "retired": 112765, "summary": "This gene encodes a member of family I of the G protein-coupled receptors, as well as the EDG family of proteins. This protein functions as a lysophosphatidic acid (LPA) receptor and contributes to Ca2+ mobilization, a critical cellular response to LPA in cells, through association with Gi and Gq proteins. An alternative splice variant has been described but its full length sequence has not been determined. [provided by RefSeq, Jul 2008].", "symbol": "LPAR2", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1414256"}, "unigene": "Hs.122575", "wikipedia": {"url_stub": "LPAR2"}}